Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary healthcare in Qatar.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Apr 2021
Historique:
revised: 06 08 2020
received: 04 06 2020
accepted: 10 08 2020
pubmed: 18 8 2020
medline: 1 2 2022
entrez: 18 8 2020
Statut: ppublish

Résumé

This study determined the prevalence and risk factors for diabetic peripheral neuropathy (DPN) and painful DPN (pDPN) in patients with type 2 diabetes in primary healthcare (PHC) and secondary healthcare (SHC) in Qatar. This was a cross-sectional multicenter study. Adults with type 2 diabetes were randomly enrolled from four PHC centers and two diabetes centers in SHC in Qatar. Participants underwent assessment of clinical and metabolic parameters, DPN and pDPN. A total of 1,386 individuals with type 2 diabetes (297 from PHC and 1,089 from SHC) were recruited. The prevalence of DPN (14.8% vs 23.9%, P = 0.001) and pDPN (18.1% vs 37.5%, P < 0.0001) was significantly lower in PHC compared with SHC, whereas those with DPN at high risk for diabetic foot ulceration (31.8% vs 40.0%, P = 0.3) was comparable. The prevalence of undiagnosed DPN (79.5% vs 82.3%, P = 0.66) was comparably high, but undiagnosed pDPN (24.1% vs 71.5%, P < 0.0001) was lower in PHC compared with SHC. The odds of DPN and pDPN increased with age and diabetes duration, and DPN increased with poor glycemic control, hyperlipidemia and hypertension, whereas pDPN increased with obesity and reduced physical activity. The prevalence of DPN and pDPN in type 2 diabetes is lower in PHC compared with SHC, and is attributed to overall better control of risk factors and referral bias due to patients with poorly managed complications being referred to SHC. However, approximately 80% of patients had not been previously diagnosed with DPN in PHC and SHC. Furthermore, we identified a number of modifiable risk factors for PDN and pDPN.

Identifiants

pubmed: 32799429
doi: 10.1111/jdi.13388
pmc: PMC8015833
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

592-600

Subventions

Organisme : Qatar National Research Fund
ID : BMRP-5726113101
Organisme : Pfizer Gulf FZ LLC
ID : W1230787

Informations de copyright

© 2020 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

Ther Adv Endocrinol Metab. 2019 Feb 04;10:2042018819826890
pubmed: 30783521
Oxid Med Cell Longev. 2015;2015:756294
pubmed: 26290682
J Int Med Res. 2011;39(2):366-77
pubmed: 21672340
Diabetologia. 1998 Nov;41(11):1263-9
pubmed: 9833931
Endocr J. 2004 Dec;51(6):563-7
pubmed: 15644575
Lancet. 2010 Aug 7;376(9739):419-30
pubmed: 20594588
Saudi J Anaesth. 2017 May;11(Suppl 1):S31-S39
pubmed: 28616002
Diabetes Res Clin Pract. 2018 May;139:147-154
pubmed: 29518491
BMJ Open Diabetes Res Care. 2020 Jun;8(1):
pubmed: 32576561
J Diabetes Complications. 2013 Sep-Oct;27(5):436-42
pubmed: 23731827
Adv Ther. 2017 Jun;34(6):1426-1437
pubmed: 28502036
Diabet Med. 2014 Dec;31(12):1673-80
pubmed: 24975286
Int Wound J. 2007 Dec;4(4):286-7
pubmed: 18154621
Diabet Med. 2002 Aug;19(8):661-6
pubmed: 12147147
J Am Board Fam Pract. 2004 Sep-Oct;17(5):309-18
pubmed: 15355943
Cent Asian J Glob Health. 2019 Jan 24;8(1):333
pubmed: 30881757
Clin Diabetes Endocrinol. 2017 Dec 28;3:12
pubmed: 29299335
Diabetes Care. 2006 Jul;29(7):1518-22
pubmed: 16801572
Diabetes Care. 2013 Oct;36(10):3208-15
pubmed: 23757426
Diabetologia. 1993 Feb;36(2):150-4
pubmed: 8458529
N Engl J Med. 2005 Jan 27;352(4):341-50
pubmed: 15673800
Diabetes Care. 2017 Jan;40(1):136-154
pubmed: 27999003
J Diabetes Investig. 2019 Nov;10(6):1558-1564
pubmed: 30860314
Prim Care Diabetes. 2014 Oct;8(3):250-5
pubmed: 24530101
Diabetes Metab. 2009 Jun;35(3):206-13
pubmed: 19297223
Diabetes Care. 1994 Jun;17(6):557-60
pubmed: 8082524
Ther Adv Endocrinol Metab. 2018 Jan;9(1):29-31
pubmed: 29344337
Diabetes Care. 2006 Jun;29(6):1294-9
pubmed: 16732011
Diabetes Metab Res Rev. 2020 May;36(4):e3286
pubmed: 31913560
Diabet Med. 2017 Sep;34(9):1185-1192
pubmed: 28722225
Diabetes Res Clin Pract. 2016 Mar;113:101-7
pubmed: 26830855
Diabet Med. 1995 Apr;12(4):307-9
pubmed: 7600744
J Clin Hypertens (Greenwich). 1999 Jul;1(1):48-54
pubmed: 11416593
Diabet Med. 1991 Feb-Mar;8(2):157-61
pubmed: 1827402
Eur J Pain. 2009 Jul;13(6):582-7
pubmed: 18782673
J Diabetes Investig. 2020 Sep;11(5):1097-1103
pubmed: 32268012
Ther Adv Chronic Dis. 2015 Jan;6(1):15-28
pubmed: 25553239
Pain. 2005 Mar;114(1-2):29-36
pubmed: 15733628
Diabetes Educ. 2011 Jul-Aug;37(4):536-48
pubmed: 21750334
Clin J Pain. 2006 Jan;22(1):97-103
pubmed: 16340598
Lancet. 1998 Dec 19-26;352(9145):1978-81
pubmed: 9872248
Arch Iran Med. 2013 Jan;16(1):17-9
pubmed: 23273229
Qual Life Res. 2015 Dec;24(12):3001-14
pubmed: 26068732
Diabetes Res Clin Pract. 1992 Oct;18(1):43-53
pubmed: 1446576
Diabet Med. 2004 Sep;21(9):976-82
pubmed: 15317601
Lancet Neurol. 2018 May;17(5):456-466
pubmed: 29598922
Diabetes Res Clin Pract. 1995 May;28(2):103-17
pubmed: 7587918
Diabetes Care. 2011 Oct;34(10):2220-4
pubmed: 21852677
Diabetes. 2011 Sep;60(9):2397-406
pubmed: 21810596
Curr Med Res Opin. 2010 Feb;26(2):337-43
pubmed: 19968592
Diabet Med. 2012 May;29(5):578-85
pubmed: 22023377
J Diabetes Complications. 2015 Nov-Dec;29(8):1066-70
pubmed: 26227575
J Neuropathol Exp Neurol. 2012 Jun;71(6):494-510
pubmed: 22588388
PLoS One. 2015 Oct 12;10(10):e0138224
pubmed: 26457582
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
Ann Saudi Med. 2007 Jan-Feb;27(1):25-31
pubmed: 17277500
Pain. 2001 May;92(1-2):147-57
pubmed: 11323136
Pain. 2004 Apr;108(3):248-257
pubmed: 15030944
Diabetologia. 2008 Apr;51(4):562-6
pubmed: 18193189
Diabetes Res Clin Pract. 2010 Jun;88(3):289-94
pubmed: 20359765
Can J Diabetes. 2015 Aug;39(4):285-95
pubmed: 25935401
Diabetes Care. 2005 Jun;28(6):1480-1
pubmed: 15920071

Auteurs

Georgios Ponirakis (G)

Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.

Tarik Elhadd (T)

National Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
National Diabetes Center, Al-Wakra Hospital, Hamad Medical Corporation, Doha, Qatar.

Subitha Chinnaiyan (S)

National Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.

Abdul H Hamza (AH)

Umm Ghuwailina Primary Health Care, Umm Ghuwailina, Qatar.

Sanaulla Sheik (S)

Al Khor Primary Health Care, Al Khor, Qatar.

Mohamed A Kalathingal (MA)

Al Daayen Primary Health Care, Al Daayen, Qatar.

Mohamed S Anodiyil (MS)

Al Rayyan Primary Health Care, Al Rayyan, Qatar.

Zeinab Dabbous (Z)

National Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.

Mashhood A Siddique (MA)

National Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.

Hamad Almuhannadi (H)

Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.

Ioannis N Petropoulos (IN)

Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.

Adnan Khan (A)

Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.

Khaled Ae Ashawesh (K)

National Diabetes Center, Al-Wakra Hospital, Hamad Medical Corporation, Doha, Qatar.

Khaled M Dukhan (KM)

National Diabetes Center, Al-Wakra Hospital, Hamad Medical Corporation, Doha, Qatar.

Ziyad R Mahfoud (ZR)

Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.

Mahmoud A Zirie (MA)

National Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.

Amin Jayyousi (A)

National Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.

Christopher Murgatroyd (C)

Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.

Mark Slevin (M)

Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.

Rayaz A Malik (RA)

Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Doha, Qatar.
Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.
National Diabetes Center, Hamad General Hospital, Hamad Medical Corporation, Doha, Qatar.
Institute of Cardiovascular Science, University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH